Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Eisai data shows sustained benefit of lecanemab in early Alzheimer’s disease

Eisai data shows sustained benefit of lecanemab in early Alzheimer’s disease
p p Read More

Four-year treatment slows cognitive decline with consistent safety profile

July 31, 2025 News

Moderna wins EU approval for updated COVID-19 vaccine

Moderna wins EU approval for updated COVID-19 vaccine
p p Read More

Spikevax authorised to target LP.8.1 variant ahead of 2025-2026 season

July 31, 2025 News

Reimagining women’s health is a global imperative

Imagine a world where women and girls do not just survive—they thrive. A world where women live longer, […]

July 31, 2025 Uncategorized

We need a broader perspective on innovations to advance a women and health agenda

Every year millions of women lose their lives to largely preventable conditions such as cardiovascular disease, complications from […]

July 31, 2025 Uncategorized

HYDRALAZINE HYDROCHLORIDE tablet [Proficient Rx LP]

Updated Date: Wed, 23 Jul 2025 00:00:00 EDT

July 31, 2025 Uncategorized

SHINGRIX (zoster vaccine recombinant, adjuvanted) kit SHINGRIX (zoster vaccine recombinant, adjuvanted) injection, solution [GlaxoSmithKline Biologicals SA]

Updated Date: Wed, 23 Jul 2025 00:00:00 EDT

July 31, 2025 Uncategorized

Reshaping research and development through women’s leadership

Across the world, women are the foundation of health systems. They serve as caregivers, nurses, frontline responders, and […]

July 30, 2025 Uncategorized

No universal health coverage without nurses

Over its long history nursing has evolved from a vocation to a professional discipline with the largest health […]

July 30, 2025 Uncategorized

Filgotinib meets phase 3 endpoint in axial spondyloarthritis trial

Filgotinib meets phase 3 endpoint in axial spondyloarthritis trial
p p Read More

Alfasigma to seek regulatory approval following OLINGUITO study success

July 30, 2025 News

NICE backs AstraZeneca’s dual immunotherapy for advanced liver cancer

NICE backs AstraZeneca’s dual immunotherapy for advanced liver cancer
p p Read More

Imfinzi and Imjudo combination recommended as first-line treatment

July 30, 2025 News

Posts navigation

Posts pagination

« Previous 1 … 74 75 76 … 1,922 Next »
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy